Antiplatelet Agents for Cancer Prevention: Current Evidences and Continuing Controversies

Over the past two decades, aspirin has emerged as a promising chemoprotective agent to prevent colorectal cancer (CRC). In 2016, the mounting evidence supporting its chemoprotective effect, from both basic science and clinical research, led the US Preventive Services Task Force to recommend regular...

Descripción completa

Detalles Bibliográficos
Autores principales: Frere, Corinne, Lejeune, Manon, Kubicek, Pierre, Faille, Dorothée, Marjanovic, Zora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895806/
https://www.ncbi.nlm.nih.gov/pubmed/31653027
http://dx.doi.org/10.3390/cancers11111639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895806/
https://www.ncbi.nlm.nih.gov/pubmed/31653027
http://dx.doi.org/10.3390/cancers11111639

Ejemplares similares